Time perception reflects individual differences in motor and non-motor symptoms of Parkinson's disease.
Journal
Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
10
06
2023
revised:
01
08
2023
accepted:
05
08
2023
medline:
11
9
2023
pubmed:
18
8
2023
entrez:
18
8
2023
Statut:
ppublish
Résumé
Decreasing dopaminergic function is at the core of Parkinson's disease (PD) motor symptoms and changes in dopaminergic action are associated with many comorbid non-motor symptoms in PD. Notably, dopaminergic signaling in the striatum has been shown to play a critical role in the perception of time. We hypothesize that patients with PD perceive time differently and in accordance with their specific comorbid non-motor symptoms and clinical state. This means that individual differences in clinical symptoms may be reflected in individual differences in timing behavior. To test this hypothesis, we recruited patients with PD and compared individual differences in patients' clinical state with their ability to judge intervals of time ranging from 500 ms to 1100 ms while on and off their prescribed dopaminergic medications. We show that medication state (on vs. off medications) did not affect timing behavior, but individual differences in timing behavior are able to predict individual differences in comorbid non-motor symptoms, duration of PD diagnosis, and prescribed dopaminergic medications. We show that comorbid impulse control disorder is associated with temporal overestimation; depression is associated with decreased temporal accuracy; and increased PD duration and prescribed levodopa monotherapy are associated with reduced temporal precision and accuracy. Observed differences in time perception are consistent with hypothesized dopaminergic mechanisms thought to underlie the respective motor and non-motor symptoms in PD. In future work, time perception tasks may augment clinical diagnosis strategies, or help disentangle the neural and cognitive mechanisms underlying PD motor and non-motor symptom etiology.
Identifiants
pubmed: 37595329
pii: S1353-8020(23)00879-9
doi: 10.1016/j.parkreldis.2023.105800
pii:
doi:
Substances chimiques
Dopamine
VTD58H1Z2X
Levodopa
46627O600J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
105800Subventions
Organisme : NIMH NIH HHS
ID : R01 MH124115
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB R01583X 1
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : F30 DA053176
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA048096
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS092701
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH121099
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Authors declare no conflict of interest.